Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now full pipeline

Sleep Disorder: full-pipeline trial registry

9 of 23 indexed Sleep Disorder trials are currently recruiting.

Corpus placement: #724 of 28,707 conditions by registered trial count.

23 US clinical trials · 9 currently recruiting · #724 of 28,707 conditions by registered trial count

Sleep Disorder: 23 US clinical trials tracked, 9 recruiting.

Sleep Disorder is the subject of 23 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition sleep-disorder

OPEN 9 | RECR 39% | LATE 2 | EARLY 2 | RANK #724 | SPON 3

Nearest open-share peer: Metastatic Colorectal Cancer (39% recruiting · 46 trials)

Breast Cancer Stage II47.8%Advanced Non-Small-Cell Lung39.1%Sleep Disorder (this)39%Anxiety Disorder30.4%Barrett's Esophagus26.1%
Open-enrollment share among volume-matched conditions near Sleep Disorder

Sleep Disorder lists 9 open slots (39% of 23 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sleep Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sleep Disorder recruits in line with its size-band peers.

    9 of 23 indexed trials (39.1%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Sleep Disorder trials is spread across many organizations.

    Massachusetts General Hospital accounts for 3 of 23 trials (13%). 20 distinct sponsors appear on at least one study for this condition label.

  3. Typical Sleep Disorder enrolment sits around 81 participants.

    Median target enrolment is 81 among the 23 trials that report a genuine target (sentinel values excluded). 12 of those (52.2%) plan for fewer than 100 participants.

  4. Sleep Disorder research is mostly interventional.

    18 interventional and 5 observational studies make up this index (78.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 31Phase 41

Open and recent trials

23 total, page 1 of 1

RECRUITING 600 participants

A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders

Itamar-Medical, Israel

NCT06093633

RECRUITING NA 456 participants

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

University of Alabama, Tuscaloo

NCT05820919

RECRUITING NA 317 participants

Home Apnea Testing in CHildren Trial

Children's Hospital of Philadelphia

NCT05382754

RECRUITING NA 300 participants

Pilot Study of BCAA on Sleep

Portland VA Medical Center

NCT03990909

RECRUITING 240 participants

Study of Disrupted Sleep in Somali Americans

Mayo Clinic

NCT05411029

RECRUITING Phase 2 200 participants

Do Endotypes Predict Response and Sequelae in OSA Patients

University of California, San Diego

NCT04875364

RECRUITING NA 178 participants

NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment

University of California, Berkeley

NCT05986604

RECRUITING Phase 3 100 participants

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

Vanda Pharmaceuticals

NCT05361707

RECRUITING 50 participants

Baker Gordon Syndrome Natural History Study

University of Missouri-Columbia

NCT06399952

ACTIVE NOT RECRUITING Phase 2 68 participants

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

M.D. Anderson Cancer Center

NCT01628029

COMPLETED 329 participants

Analysis of Sleep Study Data to Assess Depressive Burden

Medibio Limited

NCT04232267

COMPLETED NA 203 participants

Light Therapy for PD - Dose Selection

Massachusetts General Hospital

NCT04291014

COMPLETED Phase 4 108 participants

Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes

Massachusetts General Hospital

NCT03818581

COMPLETED NA 81 participants

Remote Study of NightWare for PTSD With Nightmares

NightWare

NCT03934658

COMPLETED NA 71 participants

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Gary Morrow

NCT02002533

COMPLETED NA 50 participants

Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device

National Jewish Health

NCT01234077

COMPLETED NA 46 participants

Virtual Lifestyle Medicine Comparative Effectiveness Research

Ohio University

NCT03731481

COMPLETED NA 45 participants

WatchPAT Device Validation Study Compared to Polysomnography

University of Colorado, Denver

NCT03188718

COMPLETED NA 33 participants

The Yoga and Insomnia Study

University of Pittsburgh

NCT05723211

COMPLETED 28 participants

Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment

NYU Langone Health

NCT03912571

COMPLETED NA 26 participants

The Effects of Exercise on Sleep and Brain Health

Massachusetts General Hospital

NCT04210882

COMPLETED NA 21 participants

Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment

University of California, Berkeley

NCT03556878

COMPLETED NA 14 participants

Evaluation of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea

Invicta Medical

NCT06283030

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Sleep Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

CPC M1 Device
1 trials
Fitted Transdiagnostic Sleep and Circadian intervention Behavioral
1 trials
NightWare Therapeutic System in Sham Mode Device
1 trials
NightWare Therapeutic System Device
1 trials
Brief Behavioral Therapy Behavioral
1 trials
VR-CO2 MRI Scans Diagnostic test
1 trials
MRI Based Perfusion Imaging Diagnostic test
1 trials
Structural 3T MRI Diagnostic test
1 trials

US sites by state

Facility locations filed on Sleep Disorder trials. A trial with sites in several states counts in each.

California 6 trials
New York 5 trials
Colorado 4 trials
Ohio 3 trials
Minnesota 3 trials
Massachusetts 3 trials
Texas 2 trials
Tennessee 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sleep Disorder page

23 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sleep Disorder condition card totals 23 registered trials; most-linked intervention CPC M1; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.